Abstract: A method for use of exopolysaccharides of a lactic acid bacterium or a pharmaceutical composition containing the exopolysaccharides in the manufacture of a medicament for preventing, ameliorating and/or treating a sleeping disorder in a subject in need thereof.

Abstract: Provided are compositions and methods for identifying a specific strain of Lactobacillus plantarum, e.g., Lactobacillus plantarum subsp. plantarum PS128 deposited under DSMZ Accession No. DSM 28632.

Abstract: An isolated and purified lactic acid bacteria is provided, which is Lactobacillus paracasei PS23 (PS23) and its applications in delaying aging process, improving immunomodulatory activity, reducing, preventing or treating allergic and inflammation, preventing or treating a chronic disorder and/or (vi) preventing and/or treating a mood disorder or a neurological condition.

Abstract: Provided is a composition including a lactic acid bacterium and a carrier thereof for prophylaxis or treatment of an allergy. The lactic acid bacterium is Lactobacillus paragasseri, such as Lactobacillus paragasseri BBM171 deposited under DSMZ Accession No. DSM 34311. Also provided is a method for preventing or treating an allergy in a subject that includes administering an effective amount of the composition of Lactobacillus paragasseri to the subject.

Abstract: Provided is a method of reducing a behavioral abnormality associated with a neurodevelopmental disorder in a subject, including administering to the subject an effective amount of Lactobacillus plantarum subsp. plantarum PS128. Also provided is a composition for preventing or treating a behavioral abnormality associated with a neurodevelopmental disorder in a subject in need thereof.

Abstract: This disclosure provides a method of protecting a subject for exercise that prevents an exercise-related harmful effect and reducing exercise fatigue in the subject to thereby enhance physical performance and promote anti-fatigue and anti-inflammatory effects in the subject.

Abstract: Provided are compositions and methods for identifying a specific strain of Lactobacillus plantarum, e.g., Lactobacillus plantarum subsp. plantarum PS128 deposited under DSMZ Accession No. DSM 28632.

Abstract: Provided is a method for preventing or treating an emotional or behavioral problem in a non-human animal, such as fears, phobias, anxieties and aggression, by administering a lactic acid bacterium the non-human animal in need thereof

Abstract: This disclosure provides a method of protecting a subject for exercise that prevents an exercise-related harmful effect and reducing exercise fatigue in the subject to thereby enhance physical performance and promote anti-fatigue and anti-inflammatory effects in the subject.

Abstract: The present invention relates to a coating composition, which includes: (A) a polysiloxane resin, including a unit derived from a siloxane monomer, a siloxane oligomer, or a combination thereof; and (B) inorganic particles, including first SiO2 particles with a particle size ranging from 15 nm to 100 nm, and second SiO2 particles with a particle size ranging from 3 nm to <15 nm. The present invention further relates to a coating layer for enhancing light transmittance that is formed by the coating composition. According to the present invention, by using at least two types of inorganic particles with specific particle sizes to form a geometric stack, the space of pores can be increased, and therefore, the porosity of the coating layer can be increased, thereby reducing the optical refractive index of the coating layer and achieving an effect of enhancing light transmittance.

Abstract: The present invention provides an isolated lactic acid bacterium, Lactobacillus plantarum subsp. plantarum PS128 deposited under DSMZ Accession No. DSM 28632, for prophylaxis or treatment of a stress-induced disorder. The present invention further provides a composition for prophylaxis or treatment of a stress-induced disorder that comprises Lactobacillus plantarum subsp. plantarum PS128. Moreover, the present invention provides a method for prophylaxis or treatment of a stress-induced disorder in a subject that comprises a step of administering an effective amount of Lactobacillus plantarum subsp. plantarum PS128 to the subject.

Abstract: An isolated and purified lactic acid bacteria is provided, which is Lactobacillus paracasei PS23 (PS23) and its applications in delaying aging process, improving immunomodulatory activity, reducing, preventing or treating allergic and inflammation, preventing or treating a chronic disorder and/or (vi) preventing and/or treating a mood disorder or a neurological condition.

Abstract: A wireless automatic charging system for electric vehicles is disclosed, wherein the electric vehicle comprises a charging board, a Bluetooth device, a battery, as well as a battery management module electrically connected to the aforementioned charging board, Bluetooth device and battery and capable of detecting and recording the charging efficiency data concerning the charging board, and wherein the wireless automatic charging system for electric vehicles comprises a base seat, an air inflation and deflation device, a discharging board and a control console, wherein the battery management module in the electric vehicle can transfer the charging-related information of the electric vehicle to the control console via the Bluetooth module such, and adjust the distance between the charging board and the discharging board and/or charging power of the discharging board in accordance with the received charging efficiency data and the charging efficiency adjustment data.

Abstract: A wireless automatic charging system for electric vehicles is disclosed, wherein the electric vehicle comprises a charging board, a Bluetooth device, a battery, as well as a battery management module electrically connected to the aforementioned charging board, Bluetooth device and battery and capable of detecting and recording the charging efficiency data concerning the charging board, and wherein the wireless automatic charging system for electric vehicles comprises a base seat, an air inflation and deflation device, a discharging board and a control console, wherein the battery management module in the electric vehicle can transfer the charging-related information of the electric vehicle to the control console via the Bluetooth module such, and adjust the distance between the charging board and the discharging board and/or charging power of the discharging board in accordance with the received charging efficiency data and the charging efficiency adjustment data.

Abstract: A method for inhibiting bacterial adhesion of oral pathogens, comprising administering a heat-inactivated Lactobacillus strain to a subject in need to inhibit bacterial adhesion of oral pathogens is disclosed. The Lactobacillus strain is selected from Lactobacillus paracasei GMNL-143, Lactobacillus helveticus GMNL-164 or Lactobacillus rhamnosus GMNL-464. A composition for inhibiting bacterial adhesion of oral pathogens is also disclosed.

Abstract: A method for inhibiting bacterial adhesion of oral pathogens, comprising administering a heat-inactivated Lactobacillus strain to a subject in need to inhibit bacterial adhesion of oral pathogens is disclosed. The Lactobacillus strain is selected from Lactobacillus paracasei GMNL-143, Lactobacillus helveticus GMNL-164 or Lactobacillus rhamnosus GMNL-464. A composition for inhibiting bacterial adhesion of oral pathogens is also disclosed.

Abstract: The present invention provides an isolated lactic acid bacterium, Lactobacillus plantarum subsp. plantarum K37 strain, deposited in DSME-DEUTSCHE SAMMLUNG VON MIKROORGANISMEN UND ZELLKULTUREN GmbH under Accession No. DSM 27445. The present invention further provides a pharmaceutical composition comprising the isolated lactic acid bacterium (Lactobacillus plantarum subsp. plantarum K37). Moreover, the present invention provides a method for preventing or treating a disorder in a subject, comprising a step of administering an effective amount of the isolated lactic acid bacterium (Lactobacillus plantarum subsp. plantarum K37) to the subject.

Abstract: The present invention relates to a coating composition, which includes: (A) a polysiloxane resin, including a unit derived from a siloxane monomer, a siloxane oligomer, or a combination thereof; and (B) inorganic particles, including first SiO2 particles with a particle size ranging from 15 nm to 100 nm, and second SiO2 particles with a particle size ranging from 3 nm to <15 nm. The present invention further relates to a coating layer for enhancing light transmittance that is formed by the coating composition. According to the present invention, by using at least two types of inorganic particles with specific particle sizes to form a geometric stack, the space of pores can be increased, and therefore, the porosity of the coating layer can be increased, thereby reducing the optical refractive index of the coating layer and achieving an effect of enhancing light transmittance.

Abstract: The invention provides a new lactic acid bacteria (LAB) strain with immunomodulatory and anti-inflammatory activity and a composition containing and method using the same. The LAB of the invention can be administrated for modulating an immune response in order to restore or prevent metabolic disorders caused by obesity or chronic inflammation.

Abstract: The present invention provides an isolated lactic acid bacterium, Lactobacillus plantarum subsp. plantarum PS128 deposited under DSMZ Accession No. DSM 28632, for prophylaxis or treatment of a stress-induced disorder. The present invention further provides a composition for prophylaxis or treatment of a stress-induced disorder that comprises Lactobacillus plantarum subsp. plantarum PS128. Moreover, the present invention provides a method for prophylaxis or treatment of a stress-induced disorder in a subject that comprises a step of administering an effective amount of Lactobacillus plantarum subsp. plantarum PS128 to the subject.